the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ex-director admits lots of criminality, forgery in SRC management

KUALA LUMPUR: A former SRC International Sdn Bhd director admitted at the High Court here today that there were lots of criminality and forgery in the management of the company.

In fact, Datuk Suboh Md Yassin, 73, who made the admission said the company’s former chief executive officer Nik Faisal Ariff Kamil, who is currently at large, has lied to the board of directors pertaining to the repatriation of SRC funds from overseas.

He said this when queried by Datuk Seri Najib Tun Razak’s counsel Tan Sri Muhammad Shafee Abdullah as a third-party respondent in SRC’s US$1.18 billion civil suit against the former prime minister and Nik Faisal.

Muhammad Shafee: I have proven to you and you agreed that there is a lot of forgery going on in the management?

Suboh: Yes.

Muhammad Shafee: Do you agree with me that Nik Faisal did not repatriate back the funds despite promising to the board?

Suboh: Yes.

Further questioned by the lawyer on whether there were some rogues in the management that were running the show of SRC, the witness also answered with a “yes”.

The trial before Judge Datuk Ahmad Fairuz Zainol Abidin continues tomorrow.

Under new management, SRC filed the suit in May 2021, claiming that Najib had committed a breach of trust and abuse of power, personally benefited from the company’s funds, and misappropriated the said funds.

It also seeks a court declaration holding Najib responsible for the company’s losses due to his breach of duties and trust, and for Najib to repay the RM42 million in losses the company incurred.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings